SCHEMBL18736016

SCHEMBL18736016

Oc1ccc2ccc(-c3ccc4ccccc4c3)cc2c1-c1c(O)ccc2ccc(-c3ccc4ccccc4c3)cc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.66
▸ ESR1 P03372 4/20 0.57
▸ ESR2 Q92731 4/20 0.57
▸ ACMSD Q8TDX5 1/20 0.54
▸ HSD17B1 P14061 6/20 0.53
▸ HSD17B2 P37059 6/20 0.53
▸ CYP1A2 P05177 3/20 0.50
▸ CYP3A4 P08684 2/20 0.50
▸ CYP2D6 P10635 2/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ CYP2B6 P20813 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ HDAC4 P56524 1/20 0.47
▸ HDAC2 Q92769 1/20 0.47
▸ HDAC8 Q9BY41 1/20 0.47
▸ PTPN22 Q9Y2R2 1/20 0.45
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ GSTP1 P09211 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30874112 0.89 ALOX5 (0.66) ALOX5ESR1ESR2ACMSDHSD17B1
SCHEMBL29506854 0.86 ESR2 (0.62) ALOX5ESR1ESR2ACMSDHSD17B1
SCHEMBL21360075 0.86 ESR2 (0.62) ALOX5ESR1ESR2ACMSDHSD17B1
SCHEMBL20169571 0.86 ALOX5 (0.50) ALOX5ESR1ESR2ACMSDHSD17B1
SCHEMBL25634037 0.85 ALOX5 (0.53) ALOX5ESR1ESR2ACMSDHSD17B1
SCHEMBL22795574 0.85 ALOX5 (0.60) ALOX5ESR1ESR2ACMSDHSD17B1
SCHEMBL25060829 0.84 ALOX5 (0.59) ALOX5ESR1ESR2ACMSDHSD17B1
SCHEMBL297384 0.82 ALOX5 (0.61) ALOX5ESR1ESR2ACMSDHSD17B1
SCHEMBL18704004 0.80 MCL1 (0.60) ALOX5ESR2ACMSDHSD17B1HSD17B2
SCHEMBL29587524 0.80 MCL1 (0.60) ALOX5ESR2ACMSDHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10982149-B2 Chiral compounds MERCK PATENT GMBH (DE) 2021-04-20 — — US disclosed
WO-2017059942-A1 CHIRAL COMPOUNDS MERCK PATENT GMBH (DE) 2017-04-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10982149-B2 Chiral compounds FANCI, COL1A1, LCP1 ALOX5 1942/4885ESR1 2493/4885ESR2 3609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback